Latest Schedule 13D activist filings

Ainos Inc. (Cayman Islands) filed Amendment 14 to its Schedule 13D, updating its beneficial ownership in Ainos, Inc. (Texas) to 6.76% and disclosing a minor share sale by TCNT.

Key reporting persons, including AE Red Holdings and Michael Robert Greene, have reduced their beneficial ownership in Redwire Corp through recent open market share sales.

The Terence E. Adderley Revocable Trust K completed the sale of its entire 3,039,940 Class B Common Stock stake in Kelly Services Inc. for $106 million, with a potential earn-out.

1Globe Capital LLC, 1Globe Biomedical (Hong Kong) Company Limited, and Dr. Jiaqiang Li have increased their beneficial ownership in Sinovac Biotech Ltd. to 32.3% while actively engaged in multiple ongoing legal disputes concerning corporate control and share validity.

SAIF Partners IV L.P. and YZ Healthcare L.P. have amended and restated their investment agreement concerning the sale of Sinovac Biotech Ltd. common shares, extending key option periods and clarifying terms.

Tactic Pharma LLC and its principals have ceased to be beneficial owners of more than five percent of Monopar Therapeutics common stock following a pro rata distribution to its members.

A Schedule 13D/A filing reveals a significant dilution of beneficial ownership for Kevin Xiaofeng Ma and affiliated entities in ATA Creativity Global following a recent ADS issuance.

Jun Zhang and Arts Consulting Limited report a reduced beneficial ownership stake in ATA Creativity Global following the issuer's recent issuance of new shares.

Elwood G. Norris and related entities have significantly reduced their stake in WRAP Technologies, selling over 800,000 shares and filing intent to sell an additional 1.7 million shares.

Daewoong Co., Ltd. and Daewoong Pharmaceutical Co., Ltd. have increased their beneficial ownership in AEON Biopharma, Inc. to 49.99% through an exchange of convertible notes for common stock, a new note, and warrants.

Daewoong Co., Ltd. and Daewoong Pharmaceutical Co. Ltd. report their beneficial ownership in AEON Biopharma, Inc. has fallen below 1% due to recent dilution and a reverse stock split.

David E. Lazar has filed an exit amendment for his Schedule 13D, reporting a 4.99% beneficial ownership in NovaBay Pharmaceuticals, Inc. following the conversion of preferred stock.

CASI Pharmaceuticals, Inc. has secured a $5 million convertible promissory note from ETP Global III Fund LP, marking the first tranche of a $20 million financing initiative.

Khosla Ventures and Vinod Khosla have increased their beneficial ownership in LanzaTech Global, Inc. to 64.2% following preferred stock conversion and warrant issuance.

Carl Icahn and affiliated entities have reduced their beneficial ownership in Southwest Gas Holdings, Inc. to 4.99%, ceasing to be a greater than 5% shareholder.

CDP Investissements Inc. and Caisse de depot et placement du Quebec filed an amendment to their Schedule 13D, reaffirming a 20.1% beneficial ownership in Zevia PBC.

A group of entities and individuals associated with Mario Gabelli increased their beneficial ownership in Monro, Inc. to 7.23% of outstanding common stock.

Medtronic plc, through its affiliate Covidien Group S.a.r.l., has acquired a 16.2% stake in Anteris Technologies Global Corp. for $90 million, establishing a strategic partnership.

Medtronic plc, through its affiliate Covidien Group S.a.r.l., has acquired a 16.2% stake in Anteris Technologies Global Corp. for $90 million, establishing a strategic partnership.

Oramed Pharmaceuticals Inc. and CEO Nadav Kidron have jointly acquired a 5.0% stake in Nano Dimension Ltd., signaling intent to engage with management on strategic and governance matters.

Oramed Pharmaceuticals and CEO Nadav Kidron disclose a 5% activist stake in Nano Dimension Ltd., signaling intent to influence governance and strategy.

Geo Impex LLC has reported a 24.5% beneficial ownership stake in ConnectM Technology Solutions, Inc. through a share swap.

HoldCo Asset Management and related entities have updated their beneficial ownership in Central Pacific Financial Corp, now holding up to 9.2% of common stock.

Trio-Tech International's CEO, Siew Wai Yong, increased his beneficial ownership to 16.9% of common stock through a recent option exercise, signaling continued investment.

Edward S. Lampert and affiliated entities disclose support for Lands' End's new intellectual property joint venture with WHP Global, involving a $300 million cash payment and a tender offer.

Rani R. Kohen, a key executive at SKYX Platforms Corp., has increased his beneficial ownership to 8.7% of the company's common stock, including exercisable options.

ATG Capital Opportunities Fund LP and its affiliates have increased their beneficial ownership in Empery Digital Inc. to 10.4% through recent common stock purchases.

PEP TG Investments LP, an affiliate of Providence Equity Partners, has reduced its stake in Callaway Golf Company by selling 10 million shares at $14.70 each.

An insider group, including 8 Rivers Capital and NPEH, LLC, has reduced its beneficial ownership in NET Power Inc. to 21.01% after selling 1,295,220 Class A Common Stock shares.

Steel Partners Holdings L.P. and its affiliates have reduced their beneficial ownership in Green Dot Corp Class A Common Stock to 5.7% through recent open market sales.